Storia della carriera di Omer Siddiqui
Precedenti posizioni note di Omer Siddiqui
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| HARPOON THERAPEUTICS, INC. | Corporate Officer/Principal | 03/11/2020 | 01/06/2022 |
| ALLAKOS INC. | Corporate Officer/Principal | 19/01/2016 | 01/06/2017 |
| ALECTOR, INC. | Corporate Officer/Principal | - | - |
Formazione di Omer Siddiqui
| University of Western Ontario | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 4 |
| Canada | 2 |
Posizioni
| Corporate Officer/Principal | 3 |
| Undergraduate Degree | 1 |
Settori
| Health Technology | 4 |
| Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| ALLAKOS INC. | Health Technology |
| ALECTOR, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Harpoon Therapeutics, Inc.
 Harpoon Therapeutics, Inc. BiotechnologyHealth Technology Harpoon Therapeutics, Inc. is a clinical-stage immunotherapy company, which engages in the development of antibodies. It focuses on the research of novel class of T cell engagers that harness the power of the body’s immune system to treat patients suffering from cancer and other diseases. The firm utilizes its proprietary Tri-specific T cell Activating Construct platform to create a pipeline of novel TriTACs for the treatment of solid tumors and hematologic malignancies. The company was founded by Patrick A. Baeuerle, Luke B. Evnin, and Jeanmarie Guenot on March 19, 2015 and is headquartered in South San Francisco, CA. | Health Technology |
- Borsa valori
- Insiders
- Omer Siddiqui
- Esperienza
